Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 14, 2008

View Archived Issues

Novel anticoagulants disclosed in recent Novo Nordisk patent

New treatment options for AD and other cognition disorders described in recent Roche patent

New clinical data on pazopanib presented

MDRNA selects MDR-04227 as lead candidate in hypercholesterolemia program

Recent Plexxikon and Janssen patents impart novel antiobesity drugs

Kamada presents positive phase II data for inhaled AAT in cystic fibrosis

Biodel to meet with FDA by end of January 2009 to discuss NDA for diabetes drug VIAject

Natural extract derivative found as novel PDE5A1 inhibitor with better selectivity than sildenafil

BioWa and CSL sign license agreement for Potelligent technology in ADCC-enhanced antibodies

AZD-1152-HQPA enhances oxaliplatin effects in colorectal tumor model

Pfizer presents data on asthma candidate Compound X

HE-3235 inhibits tumor growth in castration-resistant prostate cancer model

Ablynx presents update on development of Nanobodies antibody-derived therapeutic proteins

Glenmark initiates phase II study of PDE4 inhibitor oglemilast in asthma

OncoGenex achieves regulatory milestone for lead product candidate, OGX-011

Ostarine meets primary endpoint in phase II cancer cachexia trial

Avontec reports results of phase IIa AVT-02 trial in psoriasis

FDA agrees with Neurobiological to consolidate Viprinex phase III trials

R&D highlights from the UBS Global Life Sciences Conference in New York: Vical Incorporated

Revotar presents phase I data for bimosiamose 5% cream in psoriasis

Sweden grants approval to Cyto Pulse to initiate phase I/II trial of a xenogenic DNA vaccine

Genmab reaches milestone following initiation of treatment in phase I study of ofatumumab

FDA grants marketing approval to Boston Scientific's Taxus Liberte paclitaxel-eluting stent

Migenix presents update on development of Omigard for catheter-related infections

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 4, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...